CD74 Antikörper (AA 56-215)
-
- Target Alle CD74 Antikörper anzeigen
- CD74 (HLA-DR-gamma (CD74))
-
Bindungsspezifität
- AA 56-215
-
Reaktivität
- Maus
-
Wirt
- Ratte
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD74 Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), ELISA
- Kreuzreaktivität
- Maus
- Kreuzreaktivität (Details)
- Calculated cross reactivity: Mo
- Produktmerkmale
- CD74 (Invariant chain, P33, CLIP, DHLAG, HLADG, La-gamma, INVG34)
- Aufreinigung
- Purified by Protein A or G affinity chromatography.
- Immunogen
- Recombinant protein corresponding to aa56-215 from human CD74, CHO-derived (UniProt # P04441).
- Klon
- 829706
- Isotyp
- IgG1
- Top Product
- Discover our top product CD74 Primärantikörper
-
-
- Applikationshinweise
- Optimal working conditions should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Reconstitute in sterile PBS.
- Buffer
- Supplied as a lyophilized powder in PBS, Trehalose.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C
-
- Target
- CD74 (HLA-DR-gamma (CD74))
- Andere Bezeichnung
- CD74 (CD74 Produkte)
- Synonyme
- DHLAG antikoerper, HLADG antikoerper, II antikoerper, Ia-GAMMA antikoerper, CLIP antikoerper, Ii antikoerper, INVG34 antikoerper, Iclp-1 antikoerper, iclp1 antikoerper, wu:fb11f09 antikoerper, wu:fb12a01 antikoerper, wu:fb13d06 antikoerper, wu:fk94e07 antikoerper, Iclp-2 antikoerper, cd74 antikoerper, iclp2 antikoerper, zgc:123161 antikoerper, CD74 molecule antikoerper, CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) antikoerper, CD74 molecule, major histocompatibility complex, class II invariant chain a antikoerper, CD74 molecule, major histocompatibility complex, class II invariant chain b antikoerper, CD74 antikoerper, Cd74 antikoerper, cd74a antikoerper, cd74b antikoerper
- UniProt
- P04441
- Pathways
- Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Negative Regulation of intrinsic apoptotic Signaling, Cancer Immune Checkpoints
-